Network origin in Peter Donner first degree
| Entity | Entity type | Industry | |
|---|---|---|---|
DIREVO Biotech AG
 DIREVO Biotech AG Miscellaneous Commercial ServicesCommercial Services DIREVO Biotech AG researches on screening-based directed evolution of genes and proteins and applies its integrated proprietary technologies to the development of biopharmaceuticals, industrial enzymes, chemical biocatalysts and enzymes for food and feed. Its platform technologies combine efficient DNA variation methods for mutation and recombination of genes with ultra-high throughput screening technologies. The company was founded in 2000 and is headquartered in Cologne, Germany.
3
| Extinct | Miscellaneous Commercial Services | 3 |
Chart of Companies connected to the second degree
Multi-company connection
Companies connected to Peter Donner via their personal network
| Company | Sector | Related people | Main position |
|---|---|---|---|
| EVOTEC SE | Pharmaceuticals: Major | Founder | |
| HEIDELBERG PHARMA AG | Pharmaceuticals: Major | Corporate Officer/Principal | |
Biovertis AG
 Biovertis AG Pharmaceuticals: MajorHealth Technology Biovertis AG operates as a clinical stage pharmaceutical company. It develops small molecule drugs against proprietary microbial antigens. The firm discovers and develops antimicrobial drugs for infections caused by antibiotic-resistant bacterial pathogens. The company was founded by Erich Felber, Uwe von Ahsen, and Alexander Ullrich von Gabain in 2003 and is headquartered in Vienna, Austria. | Pharmaceuticals: Major | Director/Board Member | |
Gruner Böhringer AG
 Gruner Böhringer AG Engineering & ConstructionIndustrial Services Gruner Böhringer AG engages in the provision of engineering and planning services. It specializes in the areas of infrastructure construction, hydraulic and sanitary engineering, geomatics, geology, and geographic information systems. The company was founded in 1952 and is headquartered in Oberwil, Switzerland. | Engineering & Construction | Chief Tech/Sci/R&D Officer | |
| Ludwig-Maximilians-Universität München | College/University | Corporate Officer/Principal | |
Atugen AG
 Atugen AG Pharmaceuticals: MajorHealth Technology Atugen AG is a biopharmaceutical company. It develops RNAi therapeutics which focus on vivo applications in oncology and liver diseases, exploiting its proprietary oligonucleotide delivery technologies and chemically stabilized siRNA structures. Founded in 1998, the company is headquartered in Berlin, Germany | Pharmaceuticals: Major | Corporate Officer/Principal | |
| BIOFRONTERA AG | Pharmaceuticals: Major | Director/Board Member | |
| SILENCE THERAPEUTICS PLC | Miscellaneous Commercial Services | Director/Board Member |
Statistics
International
| Germany | 7 |
| Austria | 2 |
| Switzerland | 2 |
| United Kingdom | 2 |
Sectoral
| Health Technology | 7 |
| Industrial Services | 2 |
| Consumer Services | 2 |
| Commercial Services | 2 |
Operational
| Director/Board Member | 8 |
| Corporate Officer/Principal | 3 |
| Founder | 1 |
| Chief Tech/Sci/R&D Officer | 1 |
Most connected contacts
| Insiders | |
|---|---|
| Bernd O. Wetzel | 8 |
| Manfred Eigen | 2 |
| Rudiger Hauffe | 2 |
- Stock Market
- Insiders
- Peter Donner
- Company connections
